Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 14

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Total article views   HTML views PDF downloads Totals
8,176 Dovepress* 6,870+ 956 7,826
PubMed Central* 1,306 452 1,758
Totals 8,176 1,408 9,584
*Since 18 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar